DrugPatentWatch Database Preview
Mayne Pharma Intl Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for MAYNE PHARMA INTL, and what generic alternatives to MAYNE PHARMA INTL drugs are available?
MAYNE PHARMA INTL has two approved drugs.
There are five US patents protecting MAYNE PHARMA INTL drugs.
There are twenty-five patent family members on MAYNE PHARMA INTL drugs in twelve countries.
Summary for Mayne Pharma Intl
| International Patents: | 25 |
| US Patents: | 5 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Mayne Pharma Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 9,713,642 | Start Trial | Start Trial | ||||
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-002 | Aug 13, 2001 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 9,272,046 | Start Trial | Y | Start Trial | |||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 10,463,740 | Start Trial | Y | Start Trial | |||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 8,771,739 | Start Trial | Y | Start Trial | |||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 8,921,374 | Start Trial | Y | Start Trial | |||
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-001 | Jul 22, 1985 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MAYNE PHARMA INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2013-08-12 |
| ➤ Subscribe | Delayed-release Tablets | 80 mg | ➤ Subscribe | 2015-07-01 |
| ➤ Subscribe | Delayed-release Tablets | 150 mg | ➤ Subscribe | 2008-12-19 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2014-05-19 |
| ➤ Subscribe | Delayed-release Tablets | 50 mg | ➤ Subscribe | 2015-11-05 |
International Patents for Mayne Pharma Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2398643 | Start Trial |
| Canada | 2396380 | Start Trial |
| Hong Kong | 1207288 | Start Trial |
| World Intellectual Property Organization (WIPO) | 0147492 | Start Trial |
| European Patent Office | 1239831 | Start Trial |
| South Korea | 20150043296 | Start Trial |
| Brazil | 112014031706 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
